Other

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59

Tue, 2024-04-09 09:32 — mike kraft

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Read more about Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59
Log in or register to post comments

U.S, Health workers fear employers put profits before protection as CDC revisits airborne transmission guidelines

Mon, 2024-03-18 20:37 — mike kraft

Health workers fear it's profits before protection as CDC revisits airborne transmission As the CDC revisits its airborne transmission guidelines, health care workers fear the agency is repeating past mistakes about mask guidance to prevent the spread of viruses. Yahoo News

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Diagnosing COVID-19 vs RSV, Flu --some guidance

Thu, 2024-02-01 11:30 — mike kraft

Respiratory Virus Surge: Diagnosing COVID-19 vs RSV, Flu Amid the current winter wave surge of respiratory virus cases, how challenging is it for physician's to distinguish between, diagnose, and treat COVID-19 vs RSV and influenza? Kelly Wairimu Davis Medscape

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Other

Read more about Diagnosing COVID-19 vs RSV, Flu --some guidance
Log in or register to post comments

Emergency listing for Corbevax COVID vaccine approved by WHO

Tue, 2024-01-23 19:52 — mike kraft

WHO grants emergency listing for Corbevax COVID vaccine Non-exclusive licensing of the yeast strain by developers will allow others to develop effective, low-cost vaccines. CIDRAP

The World Health Organization (WHO) has approved another COVID-19 vaccine for emergency use listing (EUL): Corbevax, a recombinant protein–based vaccine developed by scientists at Texas Children's Hospital and Baylor College of Medicine.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Read more about Emergency listing for Corbevax COVID vaccine approved by WHO
Log in or register to post comments

Scientists explain why the record-shattering 2023 heat may be surpassed in 2024

Fri, 2024-01-12 19:41 — mike kraft

Scientists explain why the record-shattering 2023 heat has them on edge. Warming may be worsening The latest calculations from several science agencies showing Earth obliterated global heat records last year may seem scary. AP News

The latest calculations from several science agencies showing Earth obliterated global heat records last year may seem scary. But scientists worry that what’s behind those numbers could be even worse.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Other